Balyasny Asset Management LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Balyasny Asset Management LLC

  • $63.6 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.28 - $1.16 $146,625 - $607,450
523,664 New
523,664 $172,000
Q3 2023

Nov 14, 2023
SELL
$1.61 - $2.54 $1.34 Million - $2.12 Million
-834,072 Reduced 96.37%
31,442 $56,000
Q2 2023

Aug 14, 2023
BUY
$1.14 - $1.95 $463,813 - $793,365
406,854 Added 88.7%
865,514 $1.61 Million
Q1 2023

May 15, 2023
BUY
$1.2 - $2.19 $503,504 - $918,895
419,587 Added 1073.85%
458,660 $610,000
Q4 2022

Feb 14, 2023
BUY
$1.63 - $3.52 $63,688 - $137,536
39,073 New
39,073 $66,000

Others Institutions Holding DNA

# of Institutions
29
Shares Held
48M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $19B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email